TATE RUBLEY: Open Payments
NPI 1619298403 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,582 in 88 payments from 18 companies in 2025. Trend: 2023 $1,235 · 2024 $808 · 2025 $1,582
Food & beverage: $1,518Education: $64
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $326 |
| Corium, LLC | 15 | $260 |
| Collegium Pharmaceutical, Inc. | 13 | $189 |
| Tris Pharma Inc | 3 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $84 |
| Axsome Therapeutics, Inc. | 4 | $77 |
| Lundbeck LLC | 4 | $73 |
| Supernus Pharmaceuticals, Inc. | 4 | $61 |
| LivaNova USA, Inc. | 2 | $51 |
Products named: VRAYLAR, Azstarys, Jornay PM, REXULTI, CAPLYTA, TRINTELLIX, Auvelity, Qelbree.
Industry payments across TX — which companies pay providers there.
